By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.
A revamped plan to streamline the FDA’s guidance practices stands to be tested as President-elect Donald Trump looks to ...
"Canada has the same drugs. They're like 25 cents on the dollar," DeSantis said after the FDA approved his plan. "If I can get 25 cents on the dollar, I can save $100 million, $200 million in ...
Viatris said on Monday the U.S. Food and Drug Administration has restricted imports of 11 products made at the drugmaker's ...